Mirae Asset Global ETFs Holdings’s Immuneering IMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$123K Buy
+24,585
New +$124K ﹤0.01% 2719
2026
Q1
– Sell
-7,627
Closed -$51.3K – 3153
2025
Q4
$51.3K Buy
+7,627
New +$49K ﹤0.01% 2929
2024
Q3
– Sell
-11,389
Closed -$14.6K – 3129
2024
Q2
$14.6K Buy
+11,389
New +$18.7K ﹤0.01% 2942

Other funds holding IMRX

Mirae Asset Global ETFs Holdings's IMRX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings opened a new position in Immuneering (IMRX) in Q2 2026: 24,585 shares worth $123K. The stake represents ﹤0.01% of the portfolio and ranks #2719 among its holdings. This is a return to the name: Mirae Asset Global ETFs Holdings previously reported a position in IMRX as recently as Q4 2025.

Mirae Asset Global ETFs Holdings first reported a position in IMRX in Q2 2024 and has held it in 3 quarters since. 111 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 24,585 shares of Immuneering worth $123K as of Q2 2026.
  • Immuneering was a new Mirae Asset Global ETFs Holdings position in Q2 2026.
  • Immuneering made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2719 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Immuneering in Q2 2024 and has held it in 3 quarters since.
  • 111 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.